Akriti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.80 Cr
About Akriti Pharmaceuticals
Akriti Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 November 2003 and has a history of 21 years and three months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.80 Cr.
Priyanka Prasad and Jitendra Prasad serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2003PTC143136
- Company No.
143136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Akriti Pharmaceuticals Private Limited offer?
Akriti Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Capsules, Softgel Capsules.
Who are the key members and board of directors at Akriti Pharmaceuticals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Priyanka Prasad ![]() | Director | 14-Nov-2003 | Current |
Jitendra Prasad ![]() | Director | 07-Sep-2015 | Current |
Financial Performance of Akriti Pharmaceuticals.
Akriti Pharmaceuticals Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Akriti Pharmaceuticals?
In 2024, Akriti Pharmaceuticals had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹78.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.50 Cr
- Kotak Mahindra Bank Limited : 2.10 Cr
- Others : 1.20 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
04 Mar 2024 | Hdfc Bank Limited | ₹4.50 Cr | Open |
21 Nov 2022 | Others | ₹1.20 Cr | Open |
11 Apr 2015 | Kotak Mahindra Bank Limited | ₹2.10 Cr | Open |
How Many Employees Work at Akriti Pharmaceuticals?
Akriti Pharmaceuticals has a workforce of 169 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Akriti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akriti Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.